XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.4
IN-PROCESS RESEARCH AND DEVELOPMENT AND DEFERRED TAX LIABILITY (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Mar. 31, 2022
IfrsStatementLineItems [Line Items]    
In-process research and development $ 145,588 $ 117,388
Deferred tax liability 28,409 30,198
I M M 60 I O X Melanoma Lung Cancers [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 84,213 84,213
I M M 65 I O X Ovarian Prostate Cancers [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 32,997 32,997
I O X [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 117,210 117,210
Oncomer Saugatuck D N A Aptamers [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 178 178
Tarus Adenosine Receptors [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 27,138
Tarus Adenosine Receptors 1 [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 500
Tarus Adenosine Receptors 2 [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development 562
Tarus [Member]    
IfrsStatementLineItems [Line Items]    
In-process research and development $ 28,200